Enhancements to Volunteer Management Process Provide Greater Flexibility

A recent assessment of HOPA’s Volunteer Management Process has led to enhancements within the Volunteer Activity Center (VAC). These enhancements include the formation of the General Volunteer Interest Pool, designed to offer greater flexibility and more opportunities for greater participation.


HOPA General Volunteer Interest Pool

If you are interested in serving as a volunteer with HOPA but are open and flexible about which group you might like to join, we ask that you please apply to be a part of the general volunteer pool. Should there be additional spots available on committees, our leaders will check this pool of candidates for potential members.

If you are selected, you will receive an invitation to the specific committee along with information about the group and responsibilities. We will return to this pool throughout the year as other positions become available.

Committee Member Skill Set:

  • Varies depending on committee appointment


  • Varies depending on committee appointment

Estimated Hours Per Week:

  • Varies depending on committee appointment

Peak Activity:

  • Varies depending on committee appointment


Viatris Advisory Board


  • Commercialization of late-to-market (LTM) biosimilars: how are you ensuring LTM biosimilars are being used? Why would you use a LTM biosimilar?
  • Contracting – best practices, learnings & takeaways
  • Operationalizing a Biosimilar – How can Viatris aid in faster operationalizing of biosimilars at your Institution?

Date: September 21, 2022
Time: 8:00 am - 12:00 pm
Location: HOPA Practice Management, Washington DC
Seeking volunteers who are a current user of (Oncology) biosimilars and currently work at an Institution or large IDN/hospital system


G1 Therapeutics Advisory Board


  • Treatment patterns of CRC and the role of Myeloprotection

Date: TBD, Virtual
Location: Washington DC
# of participants: 6-10


Genentech Advisory Board


  • Pharmacist feedback on the preparation, administration, and management of bispecific antibodies to inform development of educational strategies and tactics to ensure their safe and appropriate use

Date: September 22, 2022
Location: HOPA Practice Management, Washington DC or virtual
Number of volunteers: 10


Core Quality Measures Collaborative (CQMC)

The Hematology/Oncology Pharmacy Association (HOPA) has recently joined the Core Quality Measures Collaborative (CQMC). The CQMC is a broad-based coalition of healthcare leaders working to facilitate cross-payer measure alignment through the development of core sets of measures to assess the quality of healthcare in the United States. Founded in 2015, the CQMC is a public-private partnership between America’s Health Insurance Plans (AHIP) and the Centers for Medicare & Medicaid Services (CMS) housed at the National Quality Forum (NQF). The membership is comprised of over 70 member organizations health insurance providers, primary care and specialty societies, consumer and employer groups, and other quality collaboratives. CQMC is a membership driven and funded effort with additional funding provided by CMS and AHIP. The CQMC is currently convened by the National Quality Forum (NQF) in its role as the consensus-based entity.

As a member of CQMC, HOPA is invited to appoint a non-voting representative who will be invited to participate in all CQMC meetings and discussion, but do not participate in formal votes.

We are looking for a member with expertise in measurement and participating in consensus-based groups to represent HOPA. You will also provide regular (frequency to be determined) reports to HOPA’s Quality Oversight Committee. The term of this appointment is for two years.

If you have any questions, please contact Brooke Boring, Senior Manager of Health Policy and Advocacy at This email address is being protected from spambots. You need JavaScript enabled to view it..